Rna, (Um-Sp-(2′-Deoxy-2′-Fluoro)A-Sp-Gm-Am-Am-(2′-Deoxy-2′-Fluoro)A-Cm-Um-Cm-Am-Um-Am-Gm-(2′-Deoxy-2′-Fluoro)C-Gm-(2′-Deoxy-2′-Fluoro)A-Um-Um-Gm-Cm-Am-Sp-Cm-Sp-Am), Complex With Rna (Um-Sp-Gm-Sp-Cm-Am-Am-Um-(2′-Deoxy-2′-Fluoro)C-Gm-(2′-Deoxy-2′-Fluoro)C-(2′-Deoxy-2′-Fluoro)U-(2′-Deoxy-2′-Fluoro)A-Um-Gm-Am-Gm-Um-Um-Um-Cm-Um-Am) 3′-[[(2S,4R)-1-[29-[[2-(Acetylamino)-2-Deoxy-Β-D-Galactopyranosyl]Oxy]-14,14-Bis[[3-[[3-[[5-[[2-(Acetylamino)-2-Deoxy-Β-D-Galactopyranosyl]Oxy]-1-Oxopentyl]Amino]Propyl]Amino]-3-Oxopropoxy]Methyl]-1,12,19,25-Tetraoxo-16-Oxa-13,20,24-Triazanonacos-1-Yl]-4-Hydroxy-2-Pyrrolidinyl]Methyl Hydrogen Phosphate] (1:1)

• A Phase 1/2 Study to Evaluate ALN-6400 in Adult Healthy Volunteers and Adult Patients with HHT Ended
  2025-522510-23-00 Phase I/II 3 countries Alnylam Pharmaceuticals Inc.

Showing 1–1 of 1 trials